Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials

医学 肿瘤科 回顾性队列研究 临床试验 骨髓增生异常综合症 儿科 内科学 骨髓
作者
Amir Enshaei,Ajay Vora,Christine J. Harrison,John Moppett,Anthony V. Moorman
出处
期刊:The Lancet Haematology [Elsevier BV]
卷期号:8 (11): e828-e839 被引量:31
标识
DOI:10.1016/s2352-3026(21)00304-5
摘要

High hyperdiploidy is the most common genetic subtype of childhood acute lymphoblastic leukaemia and is associated with a good outcome. However, some patients relapse and, given its prevalence, patients with high hyperdiploidy account for a large proportion of all relapses. We aimed to evaluate putative risk factors and determine the optimal pattern of trisomies for predicting outcome.We used discovery and validation cohorts from consecutive trials-UKALL97/99 (n=456) and UKALL2003 (n=725)-to develop the prognostic profile. UKALL97/99 recruited patients aged 1-18 years between Jan 1, 1997, and June 15, 2002, and UKALL2003 recruited children and young adults aged 1-24 years between Oct 1, 2003, and June 30, 2001, from the UK and Ireland who were newly diagnosed with acute lymphoblastic leukaemia. Cytogenetic and fluorescence in-situ hybridisation testing was performed on pre-treatment bone marrow samples by regional UK National Health Service genetic laboratories or centrally by the Leukaemia Research Cytogenetics Group, and results were reported using established nomenclature and definitions. We examined the prognostic effect of previously proposed genetic and non-genetic risk factors among patients with high hyperdiploid acute lymphoblastic leukaemia treated on UKALL2003. We used Bayesian information criterion, targeted projection pursuit, and multivariate analysis to identify the optimal number of trisomies, and best subset regression and multivariate analysis to identify the optimal combination. Survival analysis considered three endpoints, as follows: event-free survival, defined as time to relapse, second tumour, or death, censored at last contact; relapse rate, defined as time to relapse for those reaching complete remission, censored at death in remission or last contact; and overall survival, defined as time to death, censored at last contact.The median follow-up time for UKALL97/99 was 10·59 years (IQR 9·25-12·06) and 9·40 years (8·00-11·55) for UKALL2003. UKALL97/99 included 208 female patients and 248 male patients, and UKALL2003 included 345 female patients and 380 male patients. We deduced that the trisomic status of four chromosomes provided the optimal information for predicting outcome. The good risk profile comprised karyotypes with +17 and +18 or +17 or +18 in the absence of +5 and +20. All remaining cases were classified in the poor risk profile. The ratio of patients with good risk and poor risk was 82:18 and 80:20 in the discovery and validation cohorts, respectively. In the validation cohort, patients with the high hyperdiploid good risk profile had an improved response to treatment compared with other patients with high hyperdiploidy at 10 years (relapse rate 5% [95% CI 3-7] vs 16% [10-23]; p<0·0001; event-free survival 92% [90-94] vs 81% [73-86]; p<0·0001; and overall survival 96% [94-97] vs 86% [79-91]; p<0·0001). The outcome for high hyperdiploid poor risk patients was similar to that of patients with an intermediate cytogenetic profile. The prognostic effect of the UKALL high hyperdiploid profile was independent of minimal residual disease and the profile outperformed other high hyperdiploid risk profiles.Future clinical trials and treatment protocols using high hyperdiploidy as a risk stratification factor should consider modifying the definition beyond chromosome count to incorporate this novel UKALL high hyperdiploid profile.Blood Cancer UK.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
3秒前
4秒前
执笔画流年完成签到,获得积分10
5秒前
天机鲁比发布了新的文献求助10
5秒前
BG完成签到,获得积分10
6秒前
李健应助殿下小王子采纳,获得10
7秒前
8秒前
10秒前
bk2020113458完成签到,获得积分10
10秒前
量子星尘发布了新的文献求助50
11秒前
Jessie发布了新的文献求助10
14秒前
14秒前
Akim应助古月采纳,获得10
14秒前
14秒前
bkagyin应助牛牛采纳,获得10
15秒前
Luo发布了新的文献求助10
15秒前
16秒前
18秒前
xiaozhuzhu完成签到,获得积分10
21秒前
nihaoxjm发布了新的文献求助10
21秒前
亦玉完成签到,获得积分10
22秒前
无聊的南松完成签到,获得积分10
23秒前
24秒前
Orange应助古月采纳,获得10
25秒前
25秒前
悦耳的咖啡豆完成签到,获得积分10
28秒前
dingz完成签到,获得积分10
28秒前
领导范儿应助怡然小蚂蚁采纳,获得10
29秒前
30秒前
共享精神应助金金钟采纳,获得30
30秒前
严念桃完成签到,获得积分10
31秒前
SYLH应助Bob采纳,获得10
33秒前
昏睡的汉堡完成签到,获得积分10
33秒前
FashionBoy应助m0405采纳,获得10
33秒前
虚心的飞雪完成签到,获得积分10
34秒前
ding应助月亮不睡我不睡采纳,获得10
34秒前
34秒前
优秀笑寒完成签到,获得积分10
35秒前
CipherSage应助古月采纳,获得10
36秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3958225
求助须知:如何正确求助?哪些是违规求助? 3504388
关于积分的说明 11118283
捐赠科研通 3235682
什么是DOI,文献DOI怎么找? 1788411
邀请新用户注册赠送积分活动 871211
科研通“疑难数据库(出版商)”最低求助积分说明 802565